Next New Releases from NCBI BookshelfRozanolixizumab (Rystiggo): Therapeutic area: Generalized myasthenia gravis: Reimbursement Review [Internet].Rozanolixizumab (Rystiggo): Therapeutic area: Generalized myasthenia gravis: Reimbursement Review [Internet].